Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes
ABSTRACTObjective IDH1/2 mutations, intervening in epigenetic procedures, are frequently encountered in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Knowledge of the genetics, immunophenotypes, and mutational kinetics of IDH1/2-mutated AML can contribute to the understanding of...
Main Authors: | Vasiliki Papadopoulou, Jacqueline Schoumans, Valentin Basset, Françoise Solly, Jérôme Pasquier, Sabine Blum, Olivier Spertini |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Hematology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2023.2180704 |
Similar Items
-
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
by: Desiree Kunadt, et al.
Published: (2022-09-01) -
Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL
by: Mathieu Simonin, et al.
Published: (2021-05-01) -
IDH1-mutated relapsed or refractory AML: current challenges and future prospects
by: Megías-Vericat JE, et al.
Published: (2019-06-01) -
IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives
by: Mondesir J, et al.
Published: (2016-09-01) -
Registered report: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate
by: Oliver Fiehn, et al.
Published: (2016-02-01)